These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37526232)
1. Exploration of selected monoterpenes as potential TRPC channel family modulator in lung cancer, an Singh A; Mishra A; Meena A; Mishra N; Luqman S J Biomol Struct Dyn; 2024 Sep; 42(15):7917-7933. PubMed ID: 37526232 [TBL] [Abstract][Full Text] [Related]
2. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel. Evidence for expression of native TRPC3-TRPC4 heteromeric channels in endothelial cells. Poteser M; Graziani A; Rosker C; Eder P; Derler I; Kahr H; Zhu MX; Romanin C; Groschner K J Biol Chem; 2006 May; 281(19):13588-13595. PubMed ID: 16537542 [TBL] [Abstract][Full Text] [Related]
3. [Expression of transient receptor potential canonical channel proteins in human non-small cell lung cancer]. Zhang Q; He J; Lu W; Yin W; Yang H; Xu X; Wang D Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):612-6. PubMed ID: 20681449 [TBL] [Abstract][Full Text] [Related]
4. The phospholipid-binding protein SESTD1 is a novel regulator of the transient receptor potential channels TRPC4 and TRPC5. Miehe S; Bieberstein A; Arnould I; Ihdene O; Rütten H; Strübing C J Biol Chem; 2010 Apr; 285(16):12426-34. PubMed ID: 20164195 [TBL] [Abstract][Full Text] [Related]
5. The interaction domains of transient receptor potential canonical (TRPC)1/4 and TRPC1/5 heteromultimeric channels. Myeong J; Ko J; Hong C; Yang D; Lee KP; Jeon JH; So I Biochem Biophys Res Commun; 2016 Jun; 474(3):476-481. PubMed ID: 27131740 [TBL] [Abstract][Full Text] [Related]
6. Intracellular spermine blocks TRPC4 channel via electrostatic interaction with C-terminal negative amino acids. Kim J; Moon SH; Shin YC; Jeon JH; Park KJ; Lee KP; So I Pflugers Arch; 2016 Apr; 468(4):551-61. PubMed ID: 26631167 [TBL] [Abstract][Full Text] [Related]
7. Activation of TRPC cationic channels by mercurial compounds confers the cytotoxicity of mercury exposure. Xu SZ; Zeng B; Daskoulidou N; Chen GL; Atkin SL; Lukhele B Toxicol Sci; 2012 Jan; 125(1):56-68. PubMed ID: 21984481 [TBL] [Abstract][Full Text] [Related]
8. TRPC1 as a negative regulator for TRPC4 and TRPC5 channels. Kim J; Ko J; Myeong J; Kwak M; Hong C; So I Pflugers Arch; 2019 Aug; 471(8):1045-1053. PubMed ID: 31222490 [TBL] [Abstract][Full Text] [Related]
9. TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis. Zeng B; Yuan C; Yang X; Atkin SL; Xu SZ Curr Cancer Drug Targets; 2013 Jan; 13(1):103-16. PubMed ID: 22920441 [TBL] [Abstract][Full Text] [Related]
10. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from Nigella sativa L. that Inhibits P38 Protein: Probable Remedies for Hepatocellular Carcinoma. Tabassum H; Ahmad IZ Med Chem; 2020; 16(3):350-357. PubMed ID: 31038073 [TBL] [Abstract][Full Text] [Related]
11. Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels. Zhu Y; Lu Y; Qu C; Miller M; Tian J; Thakur DP; Zhu J; Deng Z; Hu X; Wu M; McManus OB; Li M; Hong X; Zhu MX; Luo HR Br J Pharmacol; 2015 Jul; 172(14):3495-509. PubMed ID: 25816897 [TBL] [Abstract][Full Text] [Related]
12. In silico study of carvone derivatives as potential neuraminidase inhibitors. Jusoh N; Zainal H; Abdul Hamid AA; Bunnori NM; Abd Halim KB; Abd Hamid S J Mol Model; 2018 Mar; 24(4):93. PubMed ID: 29546582 [TBL] [Abstract][Full Text] [Related]
14. TRPC4 ion channel regulations by small-molecular inhibitors and calmodulin. Zhang J; Li Z Cell Calcium; 2021 May; 95():102361. PubMed ID: 33578200 [TBL] [Abstract][Full Text] [Related]
15. A series of quinazolin-4(3H)-one-morpholine hybrids as anti-lung-cancer agents: Synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies. Tokalı FS; Şenol H; Ateşoğlu Ş; Akbaş F Chem Biol Drug Des; 2024 Jul; 104(1):e14599. PubMed ID: 39039616 [TBL] [Abstract][Full Text] [Related]
16. Dynamics simulation and in vitro studies of betulinic acid derivative with liver X receptor. Yu P; Cao W; Wang Y J Biomol Struct Dyn; 2024 Aug; 42(13):7014-7023. PubMed ID: 37498160 [TBL] [Abstract][Full Text] [Related]
17. Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice. Just S; Chenard BL; Ceci A; Strassmaier T; Chong JA; Blair NT; Gallaschun RJ; Del Camino D; Cantin S; D'Amours M; Eickmeier C; Fanger CM; Hecker C; Hessler DP; Hengerer B; Kroker KS; Malekiani S; Mihalek R; McLaughlin J; Rast G; Witek J; Sauer A; Pryce CR; Moran MM PLoS One; 2018; 13(1):e0191225. PubMed ID: 29385160 [TBL] [Abstract][Full Text] [Related]
19. Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA. Cobre AF; Maia Neto M; de Melo EB; Fachi MM; Ferreira LM; Tonin FS; Pontarolo R J Biomol Struct Dyn; 2024 Jul; 42(11):5881-5894. PubMed ID: 37394802 [TBL] [Abstract][Full Text] [Related]
20. The regulation of transient receptor potential canonical 4 (TRPC4) channel by phosphodiesterase 5 inhibitor via the cyclic guanosine 3'5'-monophosphate. Wie J; Jeong S; Kwak M; Myeong J; Chae M; Park JK; Lee SW; So I Pflugers Arch; 2017 Jun; 469(5-6):693-702. PubMed ID: 28124739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]